NewEdge Advisors’s TELA Bio TELA Stock Holding History

NewEdge Advisors’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5	Closed	-$28	–	3994
2024 Q1	$28	Buy	+5	New	+$33	﹤0.01%	3757

Other funds holding TELA

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NewEdge Advisors's TELA Position: Q2 2024 in Review

NewEdge Advisors sold out of TELA Bio (TELA) in Q2 2024, closing a stake of 5 shares — an estimated $28 sold.

NewEdge Advisors first reported a position in TELA in Q1 2024 and held it in 1 quarter. The position peaked at $28 in Q1 2024. 68 funds tracked by Wall St. Rank hold TELA as of Q2 2024.

NewEdge Advisors reported no remaining TELA Bio position as of Q2 2024 after selling out during the quarter.
NewEdge Advisors sold 5 TELA Bio shares in Q2 2024, an estimated $28.
NewEdge Advisors first reported a position in TELA Bio in Q1 2024 and held it in 1 quarter.
NewEdge Advisors's TELA Bio position peaked at $28 in Q1 2024.
68 funds tracked by Wall St. Rank held TELA Bio as of Q2 2024.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.